DiMe introduces core digital measures set to accelerate drug development for pediatric rare diseases
These open-access resources will accelerate the development of life-saving therapies, improve prioritization in drug pipelines, and reduce development costs BOSTON, Jan. 29, 2026 /PRNewswire/ -- The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results